drugset / Trial / NCT02397525
An Open-Label Study to Evaluate Retreatment With LIPO-202
NaSingle-groupOpen-labelTreatment
Summary
Evaluate the safety of three 8-week courses of treatment with LIPO-202 in non-obese patients who have central abdominal bulging. Efficacy measurements will also be collected.
Timeline
- Start
- 2015-03
- Primary completion
- 2016-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salmeterol | Other / unclassified | — | — |